In parents of children aged 1–4 years, vaccination status was significantly associated with vaccine hesitancy (odds ratio [OR], 0.116; 95% confidence interval [CI], 0.044–0.306; p = 0.001). Furthermore, after multivariable analysis, compared to the fathers, mothers wer...
Washington —Dr. Scott Gottlieb, former head of the Food and Drug Administration and a member of Pfizer's board of directors, predicted Sunday that the drug company'sCOVID-19 vaccinecould be available to children younger than 12 by early winter, a crucial development in the nation's vaccinati...
‘Children are not small adults’ Children’s vaccine trials actually start in adults. “Typically, every vaccine candidate, even for other conditions, would be evaluated first in adult patients and then in progressively younger ages,” explained Dr. Kari Simonsen, who is leading the trial of...
director of the Vaccine Education Center and an infectious diseases physician at the Children's Hospital of Philadelphia. "As many children this past year died from Covid-19 as died from influenza. And we recommend an influenza vaccine for children." ...
Next week, an FDA advisory panel will meet to discuss whether to recommend FDA authorization of the Pfizer vaccine for children aged 5 to 11. It's already available for those 12 and older.The dose used in the trial that included more than 2,200 children was 10 micrograms, while the ...
The company said on Tuesday it would enroll children in its study based on satisfactory safety data in older adolescents and young adults, but did not specify a timeline. Pfizer is racing to develop a safe and effective vaccine for the new coronavirus with rivals such as M...
Moderna says its COVID-19 vaccine strongly protects kids as young as 12. The company released the preliminary findings Tuesday based on testing on more than 3,700 12- to 17-year-olds in the United States.
[03:40.68]One important question is the amount of vaccine: [03:45.08]Pfizer gave the 12-and-older children the same amount as adults. [03:50.56]It is testing different amounts in younger children. [03:55.56]It is ...
Children participating in the study will be followed for 12 months after receiving the second vaccination. The vaccine's effectiveness, as well as its safety and reactogenicity (potential side effects like injection-site pain, headache and fever) will be studied. ...
[01:53.08]Researchers said the vaccine was nearly 91 percent effective. [01:58.68]They found 16 COVID-19 cases among children [02:03.08]receiving the placebo and three cases [02:06.48]in children who received the actual ...